Evoke Pharma Stock (NASDAQ:EVOK)

Forecast Revenue Ownership Financials Chart Transcripts

Previous Close

$2.20

52W Range

$2.01 - $12.32

50D Avg

$3.76

200D Avg

$4.73

Market Cap

$3.30M

Avg Vol (3M)

$17.85K

Beta

0.29

Div Yield

EVOK Company Profile

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Sep 25, 2013

Website

EVOK Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 24
Pharmaceutical Products	$10.25M

Fiscal year ends in Dec 24 | Currency in USD

EVOK Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$10.25T	$5.18M	$2.51M
Operating Income	$-5.20T	$-7.43M	$-7.79M
Net Income	$-5.35T	$-7.79M	$-8.16M
EBITDA	$-5.20T	$-7.29M	$-7.72M
Basic EPS	$-2.81M	$-27.97	$-31.16
Diluted EPS	$-2.81M	$-27.97	$-31.16

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q4 24Mar 13, 25 | 4:30 PM

Q4 23Mar 14, 24 | 4:30 PM

Q4 22Mar 21, 23 | 4:30 PM

Peer Comparison

Ticker	Company
BFRI	Biofrontera Inc.
AKAN	Akanda Corp.
PROC	Procaps Group S.A.
SHPH	Shuttle Pharmaceuticals Holdings, Inc.
CPIX	Cumberland Pharmaceuticals Inc.
DERM	Journey Medical Corporation
AQST	Aquestive Therapeutics, Inc.
IXHL	Incannex Healthcare Limited
RGC	Regencell Bioscience Holdings Limited
PTPI	Petros Pharmaceuticals, Inc.
PRFX	PainReform Ltd.
AVDL	Avadel Pharmaceuticals plc